Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Oncosec Medical (ONCS)

Oncosec Medical (ONCS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 16,656
  • Shares Outstanding, K 6,481
  • Annual Sales, $ 0 K
  • Annual Income, $ -39,140 K
  • 60-Month Beta 2.39
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.82

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 04/30/19
See More
  • Average Estimate -1.37
  • Number of Estimates 1
  • High Estimate -1.37
  • Low Estimate -1.37
  • Prior Year -1.80
  • Growth Rate Est. (year over year) +23.89%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.30 +11.74%
on 05/29/19
3.01 -14.62%
on 06/11/19
+0.08 (+3.21%)
since 05/24/19
3-Month
2.30 +11.74%
on 05/29/19
7.50 -65.73%
on 04/17/19
-2.44 (-48.71%)
since 03/22/19
52-Week
2.30 +11.74%
on 05/29/19
19.60 -86.89%
on 11/01/18
-11.83 (-82.15%)
since 06/22/18

Most Recent Stories

More News
Zacks.com featured highlights include: HP, Party City, AbbVie, OncoSec Medical and Pulmatrix

Zacks.com featured highlights include: HP, Party City, AbbVie, OncoSec Medical and Pulmatrix

PRTY : 6.69 (-4.43%)
PULM : 0.95 (-2.15%)
HPQ : 20.66 (-0.19%)
ONCS : 2.57 (-3.75%)
ABBV : 78.45 (-0.42%)
Bet on 5 Top Stocks With Rising P/E

Bet on these top-ranked stocks with rising P/E to realize outsized gains.

PRTY : 6.69 (-4.43%)
PULM : 0.95 (-2.15%)
HPQ : 20.66 (-0.19%)
ONCS : 2.57 (-3.75%)
ABBV : 78.45 (-0.42%)
OncoSec Announces Collaboration For TAVO(TM) In Australia With Emerge Health

OncoSec Medical Incorporated (OncoSec) (NASDAQ: ONCS), a company developing intratumoral cancer immunotherapies, and Emerge Health Pty (Emerge), the leading Australian company providing full registration,...

ONCS : 2.57 (-3.75%)
OncoSec Medical (ONCS) Looks Good: Stock Adds 6.6% in Session

OncoSec Medical (ONCS) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.

ANIK : 38.84 (-3.36%)
ONCS : 2.57 (-3.75%)
OncoSec Medical Incorporated Prices $11,000,000 Public Offering

OncoSec Medical Incorporated (OncoSec) (NASDAQ: ONCS), a late-stage cancer biotechnology company developing intratumoral gene-delivery immunotherapies, today announced the pricing of an underwritten public...

ONCS : 2.57 (-3.75%)
OncoSec to Present at ThinkEquity Conference 2019

OncoSec Medical Incorporated (OncoSec) (NASDAQ: ONCS), a company developing late-stage intratumoral cancer immunotherapies, today announced that Daniel J. O'Connor, President and Chief Executive Officer...

ONCS : 2.57 (-3.75%)
OncoSec Appoints Industry Veteran Margaret R. Dalesandro, Ph.D., to it's Board of Directors

OncoSec Medical Incorporated (OncoSec) (NASDAQ: ONCS), a company developing intratumoral cancer immunotherapies, today announced the appointment of Margaret R. Dalesandro, Ph.D., to the Company's Board...

ONCS : 2.57 (-3.75%)
OncoSec Announces Triple Combination Immunotherapy Clinical Trial Of TAVO(TM), Epacadostat And KEYTRUDA® In Squamous Cell Head And Neck (SCCHN) Cancer

OncoSec Medical Incorporated (OncoSec) (NASDAQ:ONCS), a company developing intratumoral cancer immunotherapies, today announced a triple combination clinical trial of OncoSec's TAVO(TM), epacadostat, and...

ONCS : 2.57 (-3.75%)
OncoSec Announces Collaborative Research Agreement in HER2+ Breast Cancer Evaluating the Use of TAVO(TM) in Combination with Plasmid DNA Vaccines with a World Leading Academic Medical Center

OncoSec Medical Incorporated (OncoSec) (NASDAQ: ONCS), a company developing intratumoral cancer immunotherapies, and Duke University School of Medicine, today announced that they have entered into a collaborative...

ONCS : 2.57 (-3.75%)
OncoSec Announces New Technology to Treat Deep Visceral Lesions with IL-12

OncoSec Medical Incorporated (OncoSec) (NASDAQ:ONCS), a company developing intratumoral cancer immunotherapies, today announced the development of a new, propriety technology to potentially treat pancreatic,...

ONCS : 2.57 (-3.75%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Good. Long term indicators fully support a continuation of the trend.

See More Share

Trade ONCS with:

Business Summary

OncoSec Medical Incorporated is a biomedical company engaged in the designing, development and commercialization of therapeutic oncology products. It also develops novel OMS ElectroOncology therapies and OncoSec Medical System for the treatment of solid tumors. OncoSec Medical Incorporated is based in...

See More

Key Turning Points

2nd Resistance Point 2.75
1st Resistance Point 2.66
Last Price 2.57
1st Support Level 2.49
2nd Support Level 2.42

See More

52-Week High 19.60
Fibonacci 61.8% 12.99
Fibonacci 50% 10.95
Fibonacci 38.2% 8.91
Last Price 2.57
52-Week Low 2.30

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar